Table 1 Correlation between GTSE1 and clinicopathological features in patients with HCC.
GTSE1 (n = 89) | P value | |||
|---|---|---|---|---|
Low expression (n = 47) | High expression (n = 42) | |||
1. Age (year) | ≤50 | 30 | 19 | 0.078 |
>50 | 17 | 23 | ||
2. Gender | Male | 37 | 34 | 0.794 |
Female | 10 | 8 | ||
3. Size of tumour | ≤5 cm | 19 | 19 | 0.710 |
>5 cm | 27 | 23 | ||
4. Number of tumours | 1 | 46 | 29 | <0.001** |
≥2 | 1 | 12 | ||
5. Histological differentiation | High | 2 | 4 | 0.257 |
Medium | 36 | 25 | ||
Low | 8 | 11 | ||
6. Tumour thrombus | No | 37 | 38 | 0.714 |
Yes | 3 | 5 | ||
7. Lymphnode metastasis | No | 44 | 34 | 0.291 |
Yes | 3 | 6 | ||
8. HBV DNA | ≤1e5 | 38 | 23 | 0.036* |
>1e5 | 8 | 14 | ||
9. Tumour relapse | No | 30 | 30 | 0.631 |
Yes | 15 | 12 | ||
10. AFP (ng/mL) | ≤500 | 27 | 16 | 0.016* |
>500 | 4 | 11 | ||
